Published in Front Cell Infect Microbiol on December 17, 2013
The role of viable but non-infectious developmental forms in chlamydial biology. Front Cell Infect Microbiol (2014) 0.76
The Use of Guidelines for Lower Respiratory Tract Infections in Tanzania: A Lesson from Kilimanjaro Clinicians. Ann Med Health Sci Res (2016) 0.75
New knowledge of chlamydiae and the diseases they cause. J Infect Dis (1975) 9.35
A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N Engl J Med (1986) 8.03
Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med (1992) 5.65
Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis. Microbiol Rev (1994) 4.94
Morphologic and antigenic characterization of interferon gamma-mediated persistent Chlamydia trachomatis infection in vitro. Proc Natl Acad Sci U S A (1993) 4.28
Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis (1993) 4.02
Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma. JAMA (1991) 3.99
Evidence for long-term cervical persistence of Chlamydia trachomatis by omp1 genotyping. J Infect Dis (2000) 3.86
Infections caused by Chlamydia pneumoniae strain TWAR. Clin Infect Dis (1992) 3.49
Chlamydia trachomatis: its role in tubal infertility. J Infect Dis (1985) 2.90
Chlamydial persistence: beyond the biphasic paradigm. Infect Immun (2004) 2.78
Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease. Circulation (1993) 2.70
Synovial Chlamydia trachomatis in patients with reactive arthritis/Reiter's syndrome are viable but show aberrant gene expression. J Rheumatol (1998) 2.50
Chlamydia pneumoniae--an infectious risk factor for atherosclerosis? Nat Rev Microbiol (2004) 2.34
Persistent infection of mouse fibroblasts (L cells) with Chlamydia psittaci: evidence for a cryptic chlamydial form. Infect Immun (1980) 2.20
Global stage-specific gene regulation during the developmental cycle of Chlamydia trachomatis. J Bacteriol (2003) 2.15
Association between antibody to the chlamydial heat-shock protein and tubal infertility. J Infect Dis (1993) 1.92
Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse. J Infect Dis (1998) 1.89
Pathogens and atherosclerosis: update on the potential contribution of multiple infectious organisms to the pathogenesis of atherosclerosis. Thromb Haemost (2011) 1.85
Persistent infection of mouse fibroblasts (McCoy cells) with a trachoma strain of Chlamydia trachomatis. Infect Immun (1981) 1.64
A genome-wide profiling of the humoral immune response to Chlamydia trachomatis infection reveals vaccine candidate antigens expressed in humans. J Immunol (2010) 1.55
Serum chlamydial lipopolysaccharide as a prognostic factor for a new cardiovascular event. Heart Lung (2008) 1.47
Global transcriptional upregulation in the absence of increased translation in Chlamydia during IFNgamma-mediated host cell tryptophan starvation. Mol Microbiol (2006) 1.38
Detection of Chlamydia trachomatis in fallopian tube tissue in women with postinfectious tubal infertility. Am J Obstet Gynecol (1994) 1.37
Chlamydia pneumoniae serology: interlaboratory variation in microimmunofluorescence assay results. J Infect Dis (2000) 1.36
Reactivation of Chlamydia pneumoniae lung infection in mice by cortisone. J Infect Dis (1995) 1.36
Gene expression profiles of Chlamydophila pneumoniae during the developmental cycle and iron depletion-mediated persistence. PLoS Pathog (2007) 1.33
Persistence of chlamydial antibodies after pelvic inflammatory disease. J Clin Microbiol (1986) 1.29
Detection of Chlamydia trachomatis deoxyribonucleic acid in women with tubal infertility. Fertil Steril (1993) 1.29
Transcriptional response patterns of Chlamydophila psittaci in different in vitro models of persistent infection. Infect Immun (2006) 1.28
Genome-wide identification of Chlamydia trachomatis antigens associated with tubal factor infertility. Fertil Steril (2011) 1.21
In vitro activities of azithromycin and ofloxacin against Chlamydia pneumoniae in a continuous-infection model. Antimicrob Agents Chemother (1999) 1.20
Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease. Epidemiol Infect (1997) 1.20
Chlamydia trachomatis genes whose products are related to energy metabolism are expressed differentially in active vs. persistent infection. Microbes Infect (2002) 1.19
Reactivation of chlamydial genital tract infection in mice. Infect Immun (1997) 1.17
Antibody response to chlamydial heat shock protein 60 is strongly associated with acute coronary syndromes. Circulation (2003) 1.14
Circulating immune complexes containing chlamydial lipopolysaccharide in acute myocardial infarction. Microb Pathog (1990) 1.13
Chlamydia trachomatis antigens recognized in women with tubal factor infertility, normal fertility, and acute infection. Obstet Gynecol (2012) 1.10
Proteomic analysis of differentially expressed Chlamydia pneumoniae genes during persistent infection of HEp-2 cells. Infect Immun (2002) 1.10
Reactivation of Chlamydia trachomatis lung infection in mice by cortisone. Infect Immun (1983) 1.07
Detection of anti-Chlamydia pneumoniae IgE in children with reactive airway disease. J Infect Dis (1995) 1.06
Reactivation of Chlamydia pneumoniae infection in mice by cortisone treatment. Infect Immun (1996) 1.05
Detection of Chlamydia pneumoniae in arterial tissues. J Infect Dis (2000) 1.05
Genes required for assembly and function of the protein synthetic system in Chlamydia trachomatis are expressed early in elementary to reticulate body transformation. Mol Gen Genet (1997) 1.05
Synergistic effect of persistent Chlamydia pneumoniae infection, autoimmunity, and inflammation on coronary risk. Circulation (2003) 1.04
Chlamydia trachomatis and chlamydial heat shock protein 60-specific antibody and cell-mediated responses predict tubal factor infertility. Hum Reprod (2006) 1.02
Specific IgG and IgA antibodies to Chlamydia trachomatis in infertile women. Int J Fertil (1986) 1.02
Immunoproteomic identification and serological responses to novel Chlamydia pneumoniae antigens that are associated with persistent C. pneumoniae infections. J Immunol (2008) 1.01
Conjunctival chlamydial 16S ribosomal RNA expression in trachoma: is chlamydial metabolic activity required for disease to develop? Clin Infect Dis (2006) 1.01
Chlamydia muridarum enters a viable but non-infectious state in amoxicillin-treated BALB/c mice. Microbes Infect (2012) 0.99
Inapparent ocular infection by Chlamydia trachomatis in experimental and human trachoma. Curr Eye Res (1992) 0.98
Autoimmunity to human heat shock protein 60, Chlamydia pneumoniae infection, and inflammation in predicting coronary risk. Arterioscler Thromb Vasc Biol (2002) 0.97
Comparison of chlamydial culture with Chlamydiazyme assay during erythromycin PCE treatment of Chlamydia genital infections. Sex Transm Dis (1990) 0.97
Increased circulating immune complexes in acute stroke: the triggering role of Chlamydia pneumoniae and cytomegalovirus. Stroke (2002) 0.97
Immunopathogenic consequences of Chlamydia trachomatis 60 kDa heat shock protein expression in the female reproductive tract. Cell Stress Chaperones (2010) 0.96
Protein expression profiles of Chlamydia pneumoniae in models of persistence versus those of heat shock stress response. Infect Immun (2006) 0.96
The prevalence of Chlamydia trachomatis in fresh tissue specimens from patients with ectopic pregnancy or tubal factor infertility as determined by PCR and in-situ hybridisation. J Med Microbiol (2001) 0.95
Action and reaction: Chlamydophila pneumoniae proteome alteration in a persistent infection induced by iron deficiency. Proteomics (2004) 0.93
Chlamydial antibodies in patients with previous acute anterior uveitis. Invest Ophthalmol Vis Sci (2001) 0.93
Differential expression of genes encoding membrane proteins between acute and continuous Chlamydia pneumoniae infections. Microb Pathog (2003) 0.92
Serum immunoglobulin G antibodies to chlamydial heat shock protein 60 but not to human and bacterial homologs are associated with coronary artery disease. Circulation (2002) 0.91
Chlamydia pneumoniae infection and inflammation in adults with asthma. Respiration (2004) 0.91
Chlamydia pneumoniae-specific IgE is prevalent in asthma and is associated with disease severity. PLoS One (2012) 0.90
Serologic markers for Chlamydia pneumoniae in asthma. Ann Allergy Asthma Immunol (2000) 0.90
Persistent Chlamydia pneumoniae infection in a Swedish family. Scand J Infect Dis (1996) 0.89
The transcript profile of persistent Chlamydophila (Chlamydia) pneumoniae in vitro depends on the means by which persistence is induced. FEMS Microbiol Lett (2008) 0.89
Increased aortic intima-media thickness in 11-year-old healthy children with persistent Chlamydia pneumoniae seropositivity. Arterioscler Thromb Vasc Biol (2006) 0.88
Secondary outcomes of a pilot randomized trial of azithromycin treatment for asthma. PLoS Clin Trials (2006) 0.88
Detection of Chlamydia trachomatis deoxyribonucleic acid in monkey models (Macaca nemestrina) of salpingitis by in situ hybridization: implications for pathogenesis. Am J Obstet Gynecol (1994) 0.87
Characterization of humoral immune responses to chlamydial HSP60, CPAF, and CT795 in inflammatory and severe trachoma. Invest Ophthalmol Vis Sci (2010) 0.87
Chlamydial lipopolysaccharide (cLPS) is present in atherosclerotic and aneurysmal arterial wall--cLPS levels depend on disease manifestation. Cardiovasc Pathol (2009) 0.87
Host immune response to Chlamydia pneumoniae heat shock protein 60 is associated with asthma. Eur Respir J (2001) 0.86
IFN-gamma induced persistent Chlamydia pneumoniae infection in HL and Mono Mac 6 cells: characterization by real-time quantitative PCR and culture. Microb Pathog (2004) 0.86
Persistent Chlamydia pneumoniae infection of cardiomyocytes is correlated with fatal myocardial infarction. Am J Pathol (2007) 0.86
Infections as a stimulus for coronary occlusion, obstruction, or acute coronary syndromes. Ther Adv Cardiovasc Dis (2009) 0.85
Prevalence and persistence of Chlamydia pneumoniae antibodies in healthy laboratory personnel in Finland. Clin Diagn Lab Immunol (2005) 0.84
Chlamydial lipopolysaccharide is present in serum during acute coronary syndrome and correlates with CRP levels. Atherosclerosis (2006) 0.81
Antibodies to Chlamydia trachomatis heat shock proteins Hsp60 and Hsp10 and subfertility in general population at age 31. Am J Reprod Immunol (2004) 0.81
Construction of a highly flexible and comprehensive gene collection representing the ORFeome of the human pathogen Chlamydia pneumoniae. BMC Genomics (2012) 0.80
Antigens of persistent Chlamydia pneumoniae within coronary atheroma from patients undergoing heart transplantation. J Clin Pathol (2011) 0.80
Analysis of Chlamydia pneumoniae infection in mononuclear cells by reverse transcription-PCR targeted to chlamydial gene transcripts. Med Microbiol Immunol (2011) 0.80
Amalgamation of Chlamydia pneumoniae inclusions with lipid droplets in foam cells in human atherosclerotic plaque. Virchows Arch (2008) 0.79
Immune responses to Chlamydia pneumoniae in twins in relation to gender and smoking. J Med Microbiol (1998) 0.79
Relation of secretory phospholipase A(2) and high-sensitivity C-reactive protein to Chlamydia pneumoniae infection in acute coronary syndromes. Circ J (2004) 0.78
Novel enzyme immunoassay utilizing lipopolysaccharide-binding protein as a capture molecule for the measurement of chlamydial lipopolysaccharide in serum. Diagn Microbiol Infect Dis (2005) 0.77
Recurrent pneumonia due to persistent Chlamydia pneumoniae infection. Intern Med (2002) 0.77
Application of molecular tools in the control of blinding trachoma. Am J Trop Med Hyg (2003) 0.76